We are live on ! Find out more
ACB

Aristotle Capital Boston Portfolio holdings

AUM $1.61B
1-Year Est. Return 19.82%
This Fund
S&P 500
This Quarter Est. Return
+31.11%
1 Year Est. Return
+19.82%
3 Year Est. Return
+51.6%
5 Year Est. Return
+74.11%
10 Year Est. Return
+400.29%
AUM
$3.29B
AUM Growth
+$954M
Cap. Flow
+$337M
Cap. Flow %
10.25%
Top 10 Hldgs %
20.49%
Holding
135
New
9
Increased
113
Reduced
10
Closed
3

Top Buys

Rank Stock Value
1
PPBI
Pacific Premier Bancorp
PPBI
+$43.2M
2
EVR icon
Evercore
EVR
+$18.9M
3
CALM icon
Cal-Maine
CALM
+$16.4M
4
CHRS icon
Coherus Oncology
CHRS
+$10.4M
5
BWIN
Baldwin Insurance Group
BWIN
+$10.3M

Top Sells

Rank Stock Value
1
OPB
Opus Bank Common Stock
OPB
+$37.9M
2
QDEL icon
QuidelOrtho
QDEL
+$21.1M
3
TIVO
Tivo Inc
TIVO
+$9.62M
4
NDAQ icon
Nasdaq
NDAQ
+$8.17M
5
QTS
QTS REALTY TRUST, INC.
QTS
+$8.08M

Sector Composition

Rank Sector Weight
1 Industrials 19.71%
2 Technology 16.05%
3 Healthcare 15.69%
4 Financials 12.98%
5 Consumer Discretionary 8.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QTS
1
DELISTED
QTS REALTY TRUST, INC.
QTS
$72.5M 2.2%
1,131,334
-128,502
-10% -$8.08M
EPAY
2
DELISTED
Bottomline Technologies Inc
EPAY
$71.7M 2.18%
1,412,380
+149,357
+12% +$6.67M
HMSY
3
DELISTED
HMS Holdings Corp.
HMSY
$70.8M 2.15%
2,187,079
+228,392
+12% +$6.61M
QDEL icon
4
QuidelOrtho
QDEL
$1.13B
$70.7M 2.15%
315,773
-134,397
-30% -$21.1M
CRL icon
5
Charles River Laboratories
CRL
$11.3B
$68.9M 2.09%
395,030
+34,978
+10% +$5.58M
MMSI icon
6
Merit Medical Systems
MMSI
$4.82B
$67.4M 2.05%
1,476,144
+154,766
+12% +$6.25M
CHE icon
7
Chemed
CHE
$7.16B
$66.9M 2.03%
148,210
+13,723
+10% +$6.13M
EFOR
8
Everforth Inc
EFOR
$960M
$62.6M 1.9%
939,112
+97,491
+12% +$5.17M
ITRI icon
9
Itron
ITRI
$4.48B
$62.3M 1.89%
940,663
+97,762
+12% +$6.23M
AEIS icon
10
Advanced Energy
AEIS
$10.1B
$60.7M 1.84%
895,614
+88,949
+11% +$5.3M
CRI icon
11
Carter's
CRI
$1.43B
$58.7M 1.78%
727,033
+67,094
+10% +$5.34M
NBHC icon
12
National Bank Holdings
NBHC
$1.9B
$51.1M 1.55%
1,891,861
+179,190
+10% +$4.56M
ALE
13
DELISTED
Allete
ALE
$50.3M 1.53%
920,449
+97,464
+12% +$5.53M
MTSI icon
14
MACOM Technology Solutions
MTSI
$17.4B
$48.9M 1.48%
1,423,069
+148,660
+12% +$4.34M
MNRO icon
15
Monro
MNRO
$415M
$47.5M 1.44%
865,256
+94,186
+12% +$5.01M
AIMC
16
DELISTED
Altra Industrial Motion Corp
AIMC
$46.9M 1.43%
1,473,616
+188,436
+15% +$4.98M
PPBI
17
DELISTED
Pacific Premier Bancorp
PPBI
$46.8M 1.42%
+2,156,731
New +$43.2M
ACIW icon
18
ACI Worldwide
ACIW
$6.12B
$46.2M 1.4%
1,710,294
+170,819
+11% +$4.47M
AIN icon
19
Albany International
AIN
$2.09B
$44.8M 1.36%
762,323
+80,336
+12% +$4.34M
FLWS icon
20
1-800-Flowers.com
FLWS
$252M
$43.9M 1.33%
2,190,564
-143,153
-6% -$2.82M
HLF icon
21
Herbalife
HLF
$1.3B
$42.7M 1.3%
950,213
+101,338
+12% +$3.94M
MRCY icon
22
Mercury Systems
MRCY
$5.41B
$42.4M 1.29%
539,321
+57,456
+12% +$4.7M
ROG icon
23
Rogers Corp
ROG
$2.09B
$41.8M 1.27%
335,192
+34,647
+12% +$3.71M
PBH icon
24
Prestige Consumer Healthcare
PBH
$2.47B
$41.4M 1.26%
1,102,062
-30,128
-3% -$1.2M
AZPN
25
DELISTED
ASPEN TECHNOLOGY INC
AZPN
$41.2M 1.25%
397,403
+40,322
+11% +$4.18M
1
2 3 4 5

Similar funds

SCI
S&CO Inc Boston, Massachusetts $1.61B AUM 21.39% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
BW
Browning West Los Angeles, California $1.62B AUM 22.28% 1-Year Est. Return
TLFA
True Link Financial Advisors San Francisco, California $1.62B AUM 8.33% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.62B AUM 5.91% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
PRA
Pine Ridge Advisers New York $1.62B AUM 16.97% 1-Year Est. Return

Aristotle Capital Boston's Q2 2020 Portfolio in Review

As of Q2 2020, Aristotle Capital Boston held 135 positions worth $3.29B, up 41% from $2.34B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Aristotle Capital Boston deployed $337M of net new capital in Q2 2020, opening 9 new positions and adding to 113 existing holdings. Its largest new stake was Pacific Premier Bancorp: 2,156,731 shares worth $46.8M.

By sector, the portfolio is most concentrated in Industrials at 20% of assets, down from 20% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was QuidelOrtho, an estimated $21.1M trimmed.

  • Aristotle Capital Boston's largest Q2 2020 buy was Pacific Premier Bancorp: 2,156,731 shares worth $46.8M.
  • Aristotle Capital Boston added most to iShares Core S&P Small-Cap ETF in Q2 2020, an estimated $9.3M increase.
  • Aristotle Capital Boston's biggest Q2 2020 reduction was QuidelOrtho, cutting an estimated $21.1M.
  • Aristotle Capital Boston fully exited Opus Bank Common Stock in Q2 2020, selling an estimated $37.9M.
  • Aristotle Capital Boston's ten largest holdings make up 20% of its $3.29B portfolio in Q2 2020.
  • Aristotle Capital Boston opened 9 new positions and closed 3 in Q2 2020.
  • Aristotle Capital Boston's portfolio value rose 41% quarter-over-quarter to $3.29B.

Based on Aristotle Capital Boston's 13F filing for Q2 2020, filed 14 Aug 2020.